[H]C1(C(C)N)CCC(N)C(OC2([H])C(N)CC(N)C(OC3([H])OCC(C)(O)C(NC)C3O)C2O)O1.[H]C1(C(C)NC)CCC(N)C(OC2([H])C(N)CC(N)C(OC3([H])OCC(C)(O)C(NC)C3O)C2O)O1.[H]C1(CN)CCC(N)C(OC2([H])C(N)CC(N)C(OC3([H])OCC(C)(O)C(NC)C3O)C2O)O1
Rewrite: DRUGMATRIX assay uses AB-MECA as a ligand for Adenosine A2A radioligand binding. The assay focuses on a single protein target and uses HEK293 cells and membrane fraction in vitro for binding analysis. Does the molecule work for this test?